Peptide Synthesis Market Growth, Drivers, and Opportunities

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

USD 1.44 BN

MARKET SIZE, 2029

CAGR 9.5%

(2024-2029)

389

REPORT PAGES

490

MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global peptide synthesis market is estimated to expand to a value of USD 1.44 billion in 2029 from USD 0.91 billion in 2024, growing at a CAGR of 9.5%. The rise in biopharmaceutical research and the use of synthetic peptides in vaccine development, such as mRNA vaccines, is likely to fuel market growth. The outsourcing trend for peptide synthesis services by pharmaceutical companies to reduce costs and focus on core competencies is further likely to support market expansion

KEY TAKEAWAYS

By Region

The North America peptide synthesis market accounted for a 42.7 % revenue share in 2023.
By Offerings

By offerings, the product segment is expected to register the highest CAGR of 9.7%.
By Technique

By Technique, the chemical segment will grow the fastest during the forecast period.
By Application

By Application, the therapeutic application segment will grow the fastest during the forecast period.
Company Landscape

Thermo Fisher Scientific, Agilent Technologies Inc. and Kaneka Corporation were identified as some of the star players in the peptide synthesis market (global), given their strong market share and product footprint.

The peptide synthesis market is witnessing steady growth, driven by the rise in biopharmaceutical research and the use of synthetic peptides in vaccine development, such as mRNA vaccines, is likely to fuel market growth. The outsourcing trend for peptide synthesis services by pharmaceutical companies to reduce costs and focus on core competencies is further likely to support market expansion. Technological advancements in the instruments and launch of new products in the market is further likely to drive the market growth at faster pace.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The peptide synthesis market is being reshaped by rapid technological advancements and shifting industry priorities. Growing demand for complex and high-purity peptides in therapeutics, diagnostics, and research is accelerating the adoption of automated synthesis platforms, greener chemistries, and continuous manufacturing approaches. At the same time, disruptions such as supply-chain volatility in raw materials, increasing regulatory scrutiny, and the rise of AI-driven design tools are influencing how manufacturers operate and innovate. These trends collectively push companies toward higher efficiency, scalability, and precision, ultimately fueling the need for next-generation peptide synthesis technologies and integrated service models.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Advancements in peptide therapeutics
Innovations in peptide synthesis instruments

RESTRAINTS

Impact
Level

Regulatory hurdles
High cost of peptide synthesis and instruments

OPPORTUNITIES

Impact
Level

Adoption of personalized medicine
Strategic collaborations and partnerships

CHALLENGES

Impact
Level

Immunogenicity issues
Environmental Concerns

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Advancements in peptide therapeutics

Advancements in peptide therapeutics are accelerating demand in the peptide synthesis market. As drug developers pursue more stable, targeted, and complex peptide candidates, the need for high-purity synthesis, efficient automation, and scalable manufacturing increases, positioning innovative synthesis technologies as essential enablers of next-generation therapeutic development and commercialization.

Restraint: Regulatory hurdles

Regulatory hurdles restrain the peptide synthesis market, as stringent quality requirements, complex validation processes, and evolving compliance standards increase development timelines and operational costs. Manufacturers must invest heavily in documentation, analytics, and GMP capabilities, slowing innovation and limiting the ability of smaller players to compete effectively in the peptide production landscape.

Opportunity: Adoption of personalized medicine

The growing adoption of personalized medicine presents a significant opportunity for the peptide synthesis market. As tailored therapies demand highly specific, patient-centric peptide sequences, the need for custom synthesis, rapid prototyping, and flexible manufacturing expands, driving innovation and creating new revenue streams for peptide producers and technology providers.

Challenge: Immunogenicity issues

Immunogenicity concerns pose a notable challenge in the peptide synthesis market. Unwanted immune responses can limit therapeutic efficacy, complicate clinical development, and require extensive modification of peptide structures. Addressing these risks demands advanced design strategies, rigorous testing, and added development time, ultimately slowing commercialization and increasing costs for peptide developers.

peptide-synthesis-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Scaling production of a 25-mer therapeutic peptide from small R&D batches (~10 g) to several hundred grams under GMP conditions through optimized solid-phase synthesis and purification	Enables reliable clinical and commercial supply, reduces cost per gram through process optimization, and supports faster progression of peptide drug candidates to later development stages.
	Manufacturing complex peptide APIs including long-chain and highly modified peptides for approved drugs and clinical pipelines using large-scale SPPS reactors and advanced purification technologies.	Supports commercial availability of peptide therapeutics, ensures regulatory-compliant GMP production, and enables development of more complex peptide drugs with improved stability and therapeutic profiles.
	Expansion of peptide API manufacturing capabilities through Snapdragon Chemistry to offer GMP-grade synthesis using solid-phase, liquid-phase, and hybrid approaches for commercial-scale production.	Increases global peptide API capacity, provides flexible manufacturing routes for complex peptides, and accelerates commercialization timelines for pharmaceutical clients.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The peptide synthesis market ecosystem comprises raw material and reagent suppliers (Thermofisher, Sigma Aldrich), peptide synthesis product providers (Merck, Thermofisher, Genscript). These players supply amino acids, resins, and advanced synthesizers used to produce research-grade and GMP-grade peptides. Pharmaceutical and biotech end users drive demand through the development of peptide therapeutics, vaccines, and diagnostics, while manufacturers ensure high-purity, scalable production. Close collaboration across suppliers, technology developers, and CDMOs enables innovation in synthesis efficiency, complex peptide design, and commercialization, supporting the market’s overall expansion.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Peptide Synthesis Market, By Offerings

As of 2023, products accounted for the largest share of the peptide synthesis market by offerings and are expected to maintain their lead through 2025. This dominance is driven by strong demand for peptide synthesizers, chromatography systems, and associated hardware that enable high-quality, scalable peptide production. These technologies form the backbone of research and commercial manufacturing, offering improved automation, precision, and throughput. Continuous advancements in instrument performance and integration further reinforce the position of products as the primary revenue-generating segment in the peptide synthesis market.

By Product Type

As of 2023, consumables dominated the product type segment of the peptide synthesis market and are expected to maintain their lead through 2024. The consistent need for amino acids, resins, linkers, and coupling reagents in every synthesis cycle drives steady demand. Their critical role in ensuring high purity, efficiency, and yield across research and commercial manufacturing makes consumables the strongest revenue contributor within the overall product portfolio. Continuous improvements in reagent chemistry and greener materials further strengthen their leading position in the market.

By Service Type

As of 2023, the peptide synthesis dominated the service segment, and this leadership is expected to continue through 2024. Increasing outsourcing of custom peptide production, complex modifications, and GMP-grade manufacturing drives strong demand for specialized service providers. Pharmaceutical and biotech companies rely on CDMOs for expertise, scalability, and rapid turnaround, making services the preferred choice across research, clinical development, and commercial supply. This sustained dependence strengthens the service segment’s position as the largest contributor in the peptide synthesis market.

By Technique

The chemical methods dominated the techniques segment of the peptide synthesis market. Its strong position is driven by the widespread use of solid-phase and solution-phase chemical synthesis, which offer high efficiency, flexibility, and suitability for complex peptide sequences. Chemical techniques enable precise control over chain elongation, modifications, and purity, making them the standard approach for both research-grade and GMP-grade peptide production. This reliability and scalability continue to support their dominance across academic, pharmaceutical, and commercial manufacturing settings.

By Application

the therapeutic application segment dominated the peptide synthesis market . Growing development of peptide-based drugs for metabolic disorders, oncology, infectious diseases, and rare conditions drives strong demand for high-purity, scalable peptide production. Pharmaceutical companies increasingly prioritize peptides for their specificity, safety, and clinical effectiveness, reinforcing the dominance of therapeutic applications within the overall market.

By Product End user

pharmaceutical and biotechnology companies dominated the product end-user segment. Their strong demand for high-purity peptides used in drug discovery, preclinical research, and clinical development drives substantial consumption of synthesis instruments and related technologies. The expanding pipelines of peptide-based therapeutics and biologics further reinforce the prominence of pharma and biotech companies as the primary end users of peptide synthesis products.

By Service End user

pharmaceutical and biotechnology companies dominated the service end-user segment. Their increasing reliance on outsourced peptide design, custom synthesis, complex modifications, and GMP manufacturing drives strong demand for specialized CDMOs. The need for scalable production, regulatory compliance, and faster development timelines ensures that pharma and biotech companies remain the largest consumers of peptide synthesis services.

REGION

Asia Pacific to be fastest-growing region in global pepdite synthesis market during forecast period

The Asia Pacific peptide synthesis market is expected to register the highest CAGR during the forecast period, driven by rapid expansion of biotechnology research, growing investments in pharmaceutical manufacturing, and increasing adoption of peptide-based therapeutics. Countries such as China, India, Japan, and South Korea are accelerating capabilities in custom synthesis, GMP production, and advanced automation technologies to support both domestic and global drug development. Rising clinical activity, government support for biologics and innovative therapies, and the presence of a fast-growing biotech ecosystem further strengthen Asia Pacific’s position as the fastest-growing region in the peptide synthesis market

peptide-synthesis-market: COMPANY EVALUATION MATRIX

In the peptide synthesis market matrix, Agilent (Star) leads with a strong market share and a broad product and service footprint, driven by its advanced peptide synthesizers, high-purity reagents, and robust custom synthesis capabilities widely adopted across pharmaceutical, biotech, and academic research. Biosynth (Emerging Leader) is rapidly gaining traction with its expanding portfolio of specialty amino acids, protected building blocks, and custom peptide production services, strengthening its position through innovation and high-quality niche offerings. While Thermo Fisher maintains dominance through scale, global reach, and integrated solutions, Biosynth shows strong potential to advance toward the leaders’ quadrant as demand for complex, high-purity peptides continues to accelerate across therapeutic and research applications.

peptide-synthesis-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

Thermo Fisher Scientific (US)
Merck KGaA (Germany)
Agilent Technologies (US)
GenScript Biotech (China)
Kaneka Corporation (Japan)
Bachem Holding AG (Switzerland)
Syngene International (India)
Mesa Labs (US)
Biotage (Sweden)
CEM Corporation (US)
Dalton Pharma Services (Canada)
Bio-Synthesis Inc. (US)
CSBio (US)
ProteoGenix (France)
Innovagen AB (Sweden)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2023 (Value)	USD 0.86 Billion
Market Forecast in 2029 (Value)	USD 1.44 Billion
Growth Rate	CAGR of 9.5% from 2024-2029
Years Considered	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Million/Billion)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Offerings: Product Services By Product Type: Consumables Intsruments By Service Type: Peptide synthesis Peptide purification services peptide library services peptide analysis services By Technique : Chemical methods Biological methods By Application: Therapeutic application diagnostic application discovery & development application By Product end users: Pharma and biotechnology companies CDMOs & CROs Academic & Research Institutes Medical Device Companies Hospitals and Diagnostic Centers By Service end users: Pharma and biotechnology companies CDMOs & CROs Academic & Research Institutes Medical Device Companies Hospitals and Diagnostic Centers
Regions Covered	North America, Asia Pacific, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: peptide-synthesis-market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Academic Research Institute	Mapping availability of research-grade peptides, specialized building blocks, and modified amino acids Benchmarking pricing and delivery timelines from global suppliers	Improve procurement efficiency Access broader supplier ecosystem Reduce project timelines with optimized sourcing
Peptide CDMO	Competitive benchmarking of global CDMOs (capacity utilization, client mix, synthesis capability, purity levels) Analysis of demand shifts toward complex peptides and peptide–drug conjugates Partnership and collaboration opportunity mapping	Insights on growing composite adoption in commercial aircraft Pinpoint cross-industry substitution risks Enable targeting of high-growth aerospace programs

RECENT DEVELOPMENTS

August 2023 : GenScript enhanced its peptide production capabilities by introducing fast-track cGMP neoantigen peptides and APIs. These offerings are produced at the company's state-of-the-art life sciences manufacturing facility in Zhenjiang, building on GenScript's extensive expertise in high-quality peptide manufacturing.
February 2023 : GenScript Biotech Corporation,expanded its Singapore facility to enhance its premium gene synthesis services. The expansion adds 976 square meters, increasing the facility's total production space to 3,500 square meters, making it the third-largest GenScript facility globally.
April 2021 : AnaSpec, a subsidiary of Kaneka Corporation, expanded its GMP manufacturing facilities by adding downstream work to enhance its manufacturing capabilities.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

RESEARCH METHODOLOGY

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Explore how innovations and strategic collaborations drive growth in peptide therapeutics amidst regulatory challenges.

5.1

INTRODUCTION

5.2

MARKET DYNAMICS

5.2.1

DRIVERS

5.2.1.1

ADVANCEMENTS IN PEPTIDE THERAPEUTICS

5.2.1.2

INNOVATIONS IN PEPTIDE SYNTHESIS INSTRUMENTS

5.2.1.3

GROWING USE OF PEPTIDES IN DIAGNOSTICS AND RESEARCH

5.2.2

RESTRAINTS

5.2.2.1

REGULATORY HURDLES

5.2.2.2

HIGH COST OF PEPTIDE SYNTHESIS AND INSTRUMENTS

5.2.3

OPPORTUNITIES

5.2.3.1

ADOPTION OF PERSONALIZED MEDICINE

5.2.3.2

STRATEGIC COLLABORATIONS AND PARTNERSHIPS

5.2.4

CHALLENGES

5.2.4.1

IMMUNOGENICITY ISSUES

5.2.4.2

ENVIRONMENTAL CONCERNS

5.3

TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

5.4

PRICING ANALYSIS

5.4.1

AVERAGE SELLING PRICE TREND, BY KEY PLAYER

5.4.2

AVERAGE SELLING PRICE TREND, BY REGION

5.5

SUPPLY CHAIN ANALYSIS

5.6

VALUE CHAIN ANALYSIS

5.7

ECOSYSTEM ANALYSIS

5.7.1

PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS

5.7.2

PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS

5.7.3

PEPTIDE SYNTHESIS MARKET: END USERS

5.7.4

PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES

5.8

INVESTMENT AND FUNDING SCENARIO

5.9

TECHNOLOGY ANALYSIS

5.9.1

KEY TECHNOLOGIES

5.9.1.1

SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)

5.9.1.2

LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS)

5.9.1.3

ENZYMATIC PEPTIDE SYNTHESIS

5.9.1.4

CONTINUOUS-FLOW PEPTIDE SYNTHESIS

5.9.2

COMPLEMENTARY TECHNOLOGIES

5.9.2.1

LABELING AND TRACKING TECHNOLOGIES

5.9.2.2

PURIFICATION TECHNIQUES

5.9.3

ADJACENT TECHNOLOGIES

5.9.3.1

CELL-FREE PROTEIN SYNTHESIS

5.9.3.2

PROTEIN DESIGN AND ENGINEERING

5.10

PATENT ANALYSIS

5.11

TRADE ANALYSIS

5.11.1

TRADE DATA FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS)

5.11.1.1

IMPORT DATA FOR HS CODE 902720

5.11.1.2

EXPORT DATA FOR HS CODE 902720

5.11.2

TRADE DATA FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS AND SPRAY DRYERS)

5.11.2.1

IMPORT DATA FOR HS CODE 841993

5.11.2.2

EXPORT DATA FOR HS CODE 841933

5.12

KEY CONFERENCES AND EVENTS, 2025–2026

5.13

REGULATORY LANDSCAPE

5.13.1

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.13.2

REGULATORY FRAMEWORK

5.13.2.1

NORTH AMERICA

5.13.2.2

EUROPE

5.13.2.3

ASIA PACIFIC

5.13.2.4

LATIN AMERICA

5.13.2.5

MIDDLE EAST & AFRICA

5.14

PORTER’S FIVE FORCES ANALYSIS

5.14.1

BARGAINING POWER OF SUPPLIERS

5.14.2

BARGAINING POWER OF BUYERS

5.14.3

THREAT OF NEW ENTRANTS

5.14.4

THREAT OF SUBSTITUTES

5.14.5

INTENSITY OF COMPETITIVE RIVALRY

5.15

KEY STAKEHOLDERS AND BUYING CRITERIA

5.15.1

KEY STAKEHOLDERS IN BUYING PROCESS

5.15.2

BUYING CRITERIA

5.16

IMPACT OF AI/GENERATIVE AI ON PEPTIDE SYNTHESIS MARKET

5.16.1

INTRODUCTION

5.16.2

IMPACT OF AI ON PEPTIDE SYNTHESIS ECOSYSTEM

5.16.3

FUTURE OF GENERATIVE AI IN PEPTIDE SYNTHESIS ECOSYSTEM

PEPTIDE SYNTHESIS MARKET, BY OFFERING

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 15 Data Tables

122

6.1

INTRODUCTION

6.2

PRODUCTS

6.2.1

INCREASING ADOPTION OF SOLID AND LIQUID-PHASE PEPTIDE SYNTHESIS TO STIMULATE GROWTH

6.3

SERVICES

6.3.1

GROWING ADVANCEMENTS IN PEPTIDE DESIGN AND SYNTHESIS OPTIMIZATION TO FUEL MARKET

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 124 Data Tables

130

7.1

INTRODUCTION

7.2

CONSUMABLES

7.2.1

REAGENTS

7.2.1.1

RESINS

7.2.1.2

AMINO ACIDS

7.2.1.3

COUPLING REAGENTS

7.2.1.4

DYES & FLUORESCENT LABELING REAGENTS

7.2.1.5

DEPROTECTION REAGENTS

7.2.1.6

CLEAVAGE REAGENTS

7.2.1.7

OTHER REAGENTS

7.2.2

OTHER CONSUMABLES

7.3

INSTRUMENTS

7.3.1

PEPTIDE SYNTHESIZERS

7.3.1.1

AUTOMATED PEPTIDE SYNTHESIZERS

7.3.1.2

MANUAL PEPTIDE SYNTHESIZERS

7.3.2

CHROMATOGRAPHY SYSTEMS

7.3.2.1

INCREASING SHIFT TOWARD HIGH-THROUGHPUT AND INDUSTRIAL-SCALE PEPTIDE PRODUCTION TO AMPLIFY GROWTH

7.3.3

LYOPHILIZERS

7.3.3.1

RISING INFLUENCE OF CONTRACT MANUFACTURING ORGANIZATIONS TO ENCOURAGE GROWTH

7.3.4

OTHER INSTRUMENTS

PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 29 Data Tables

185

8.1

INTRODUCTION

8.2

PEPTIDE SYNTHESIS

8.2.1

RISING ADOPTION OF PERSONALIZED MEDICINES AND TARGETED THERAPIES TO INTENSIFY GROWTH

8.3

PEPTIDE PURIFICATION SERVICES

8.3.1

GROWING EMPHASIS ON HIGH-QUALITY PEPTIDES IN PHARMACEUTICAL DEVELOPMENT AND BIOTECH TO DRIVE MARKET

8.4

PEPTIDE LIBRARY SYNTHESIS

8.4.1

INCREASING FOCUS ON SYNTHETIC BIOLOGY TO AUGMENT GROWTH

8.5

PEPTIDE ANALYSIS SERVICES

8.5.1

INCREASING ADVANCEMENTS IN MASS SPECTROMETRY AND CHROMATOGRAPHY TO BOLSTER GROWTH

PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 52 Data Tables

200

9.1

INTRODUCTION

9.2

CHEMICAL METHODS

9.2.1

SOLID-PHASE PEPTIDE SYNTHESIS

9.2.1.1

INCREASING USE OF PEPTIDES AND PEPTIDE DERIVATIVES IN MODERN MEDICINES USE TO ENCOURAGE GROWTH

9.2.2

LIQUID-PHASE PEPTIDE SYNTHESIS

9.2.2.1

GROWING ADVANCEMENTS IN PURIFICATION TECHNOLOGIES TO BOOST MARKET

9.2.3

OTHER CHEMICAL METHODS

9.3

BIOLOGICAL METHODS

9.3.1

RECOMBINANT DNA TECHNOLOGY

9.3.1.1

INCREASING INNOVATIONS IN GENETIC ENGINEERING AND SYNTHETIC BIOLOGY TO DRIVE MARKET

9.3.2

ENZYMATIC SYNTHESIS

9.3.2.1

GROWING SHIFT TOWARD SUSTAINABLE AND ECO-FRIENDLY MANUFACTURING TO PROPEL MARKET

PEPTIDE SYNTHESIS MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 87 Data Tables

225

10.1

INTRODUCTION

10.2

THERAPEUTIC APPLICATIONS

10.2.1

THERAPEUTIC APPLICATIONS, BY INDICATION

10.2.1.1

CANCER

10.2.1.2

DIABETES

10.2.1.3

OBESITY

10.2.1.4

AUTOIMMUNE DISEASES

10.2.1.5

OTHER DISEASES

10.2.2

THERAPEUTIC APPLICATIONS, BY MOLECULE

10.2.2.1

PEPTIDE-BASED VACCINES

10.2.2.2

PEPTIDE-DRUG CONJUGATES

10.2.2.3

PEPTIDE INHIBITORS

10.2.2.4

OTHER MOLECULES

10.3

DIAGNOSTIC APPLICATIONS

10.3.1

RISE OF PERSONALIZED MEDICINE AND POINT-OF-CARE TESTING TO ACCELERATE GROWTH

10.4

DISCOVERY & DEVELOPMENT APPLICATIONS

10.4.1

GROWING ADVANCEMENTS IN COMBINATORIAL CHEMISTRY AND HIGH-THROUGHPUT PEPTIDE LIBRARIES TO DRIVE MARKET

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 36 Data Tables

268

11.1

INTRODUCTION

11.2

PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

11.2.1

INCREASING RESEARCH ON GENOMICS AND MOLECULAR BIOLOGY TO EXPEDITE GROWTH

11.3

CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS

11.3.1

SHIFT TOWARD CUSTOM AND MODIFIED PEPTIDES TO DRIVE MARKET

11.4

ACADEMIC & RESEARCH INSTITUTES

11.4.1

INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO SUPPORT GROWTH

11.5

MEDICAL DEVICE COMPANIES

11.5.1

BOOMING PEPTIDE-BASED DRUG DELIVERIES TO PROMOTE GROWTH

11.6

HOSPITALS & DIAGNOSTIC CENTERS

11.6.1

RISING DEMAND FOR PEPTIDE-BASED DIAGNOSTICS TO FAVOR GROWTH

PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 36 Data Tables

287

12.1

INTRODUCTION

12.2

PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES

12.2.1

INCREASING FOCUS ON PEPTIDE-BASED THERAPEUTICS IN ONCOLOGY AND METABOLIC DISORDERS TO INTENSIFY GROWTH

12.3

MEDICAL DEVICE COMPANIES

12.3.1

NEED TO DETECT INFECTIOUS DISEASES, CANCER, AND METABOLIC DISORDERS TO AID GROWTH

12.4

HOSPITALS & DIAGNOSTIC CENTERS

12.4.1

RISING USE OF PEPTIDE BIOMARKERS TO SUPPORT GROWTH

12.5

ACADEMIC & RESEARCH INSTITUTES

12.5.1

GROWING FOCUS ON DRUG DESIGN, VACCINE DEVELOPMENT, AND CANCER RESEARCH TO BOOST MARKET

12.6

CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS

12.6.1

INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO FACILITATE GROWTH

PEPTIDE SYNTHESIS MARKET, BY REGION

Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 432 Data Tables.

306

13.1

INTRODUCTION

13.2

NORTH AMERICA

13.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

13.2.2

13.2.2.1

WELL-DEVELOPED HEALTHCARE AND RESEARCH INFRASTRUCTURE TO AID GROWTH

13.2.3

CANADA

13.2.3.1

INCREASING GOVERNMENT FUNDING FOR ADVANCED DRUGS TO AMPLIFY GROWTH

13.3

EUROPE

13.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

13.3.2

GERMANY

13.3.2.1

GERMANY TO HOLD LARGEST MARKET SHARE IN EUROPE

13.3.3

13.3.3.1

INCREASING PEPTIDE SYNTHESIS RESEARCH TO CONTRIBUTE TO GROWTH

13.3.4

FRANCE

13.3.4.1

FAVORABLE GOVERNMENT INITIATIVES TO AUGMENT GROWTH

13.3.5

ITALY

13.3.5.1

GROWING PUBLIC AND PRIVATE SECTOR INVESTMENTS TO PROPEL MARKET

13.3.6

SPAIN

13.3.6.1

RISING FOCUS ON ADVANCED THERAPIES TO EXPEDITE GROWTH

13.3.7

REST OF EUROPE

13.4

ASIA PACIFIC

13.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

13.4.2

CHINA

13.4.2.1

EXPANDING BIOPHARMA SECTOR TO ADVANCE GROWTH

13.4.3

JAPAN

13.4.3.1

GROWING GERIATRIC POPULATION TO FUEL MARKET

13.4.4

INDIA

13.4.4.1

INCREASING INVESTMENTS AND DEVELOPMENTS IN BIOTECHNOLOGY TO FAVOR GROWTH

13.4.5

SOUTH KOREA

13.4.5.1

BOOMING BIOTECHNOLOGY SECTOR TO AMPLIFY GROWTH

13.4.6

AUSTRALIA

13.4.6.1

INCREASING GOVERNMENT FUNDING AND INITIATIVES TO AUGMENT GROWTH

13.4.7

REST OF ASIA PACIFIC

13.5

LATIN AMERICA

13.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

13.5.2

BRAZIL

13.5.2.1

GROWING INTEREST IN PEPTIDE-BASED DRUGS TO FUEL MARKET

13.5.3

MEXICO

13.5.3.1

INCREASING INITIATIVES FOR STEM CELL RESEARCH AND REGENERATIVE MEDICINE PROJECTS TO FOSTER GROWTH

13.5.4

REST OF LATIN AMERICA

13.6

MIDDLE EAST

13.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST

13.6.2

GCC COUNTRIES

13.6.2.1

SAUDI ARABIA

13.6.2.2

UAE

13.6.2.3

REST OF GCC COUNTRIES

13.6.3

REST OF MIDDLE EAST

13.7

AFRICA

13.7.1

INCREASING INVESTMENTS IN PHARMACEUTICAL INFRASTRUCTURE AND LIFE SCIENCE INNOVATIONS TO BOOST MARKET

13.7.2

MACROECONOMIC OUTLOOK FOR AFRICA

COMPETITIVE LANDSCAPE

Discover key strategies driving market dominance in peptide synthesis and emerging competitive players.

482

14.1

OVERVIEW

14.2

KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025

14.2.1

OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET

14.3

REVENUE ANALYSIS, 2019–2023

14.4

MARKET SHARE ANALYSIS, 2023

14.5

COMPANY VALUATION AND FINANCIAL METRICS

14.5.1

COMPANY VALUATION

14.5.2

FINANCIAL METRICS

14.6

BRAND/PRODUCT COMPARISON

14.7

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023

14.7.1

STARS

14.7.2

EMERGING LEADERS

14.7.3

PERVASIVE PLAYERS

14.7.4

PARTICIPANTS

14.7.5

COMPANY FOOTPRINT: KEY PLAYERS, 2023

14.7.5.1

COMPANY FOOTPRINT

14.7.5.2

REGION FOOTPRINT

14.7.5.3

OFFERING FOOTPRINT

14.7.5.4

TECHNIQUE FOOTPRINT

14.7.5.5

APPLICATION FOOTPRINT

14.8

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023

14.8.1

PROGRESSIVE COMPANIES

14.8.2

RESPONSIVE COMPANIES

14.8.3

DYNAMIC COMPANIES

14.8.4

STARTING BLOCKS

14.8.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023

14.8.5.1

DETAILED LIST OF KEY STARTUPS/SMES

14.8.5.2

COMPETITIVE BENCHMARKING OF STARTUPS/SMES

14.9

COMPETITIVE SCENARIO

14.9.1

PRODUCT LAUNCHES

14.9.2

DEALS

14.9.3

EXPANSIONS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

503

15.1

KEY PLAYERS

15.1.1

THERMO FISHER SCIENTIFIC INC.

15.1.1.1

BUSINESS OVERVIEW

15.1.1.2

PRODUCTS/SERVICES OFFERED

15.1.1.3

RECENT DEVELOPMENTS

15.1.1.4

MNM VIEW

15.1.2

MERCK KGAA

15.1.3

AGILENT TECHNOLOGIES, INC.

15.1.4

GENSCRIPT

15.1.5

KANEKA CORPORATION

15.1.6

BACHEM

15.1.7

SYNGENE INTERNATIONAL LIMITED

15.1.8

MESA LABS, INC.

15.1.9

BIOTAGE

15.1.10

CEM CORPORATION

15.1.11

DALTON PHARMA SERVICES

15.1.12

BIO-SYNTHESIS INC.

15.1.13

CSBIO

15.1.14

PROTEOGENIX

15.1.15

INNOVAGEN AB

15.1.16

BIOSYNTH

15.2

OTHER PLAYERS

15.2.1

AURIGENE PHARMACEUTICAL SERVICES LTD.

15.2.2

CORDENPHARMA

15.2.3

JPT PEPTIDE TECHNOLOGIES

15.2.4

PUROLITE

15.2.5

BIOMATIK

15.2.6

CPC SCIENTIFIC INC.

15.2.7

ADVANCED CHEMTECH, INC.

15.2.8

AMBIOPHARM INC.

15.2.9

LUXEMBOURG BIO TECHNOLOGIES

15.2.10

AAPPTEC

15.2.11

ANYGEN

15.2.12

CHEMPEP

15.2.13

PROTEOGENIX

APPENDIX

556

16.1

DISCUSSION GUIDE

16.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

16.3

CUSTOMIZATION OPTIONS

16.4

RELATED REPORTS

16.5

AUTHOR DETAILS

LIST OF TABLES

TABLE 1

PEPTIDE SYNTHESIS MARKET: INCLUSIONS AND EXCLUSIONS

TABLE 2

IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS

TABLE 3

PEPTIDE SYNTHESIS MARKET: RISK ANALYSIS

TABLE 4

PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS

TABLE 5

AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2022–2024

TABLE 6

AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2022–2024

TABLE 7

PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS

TABLE 8

PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS

TABLE 9

PEPTIDE SYNTHESIS MARKET: END USERS

TABLE 10

PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES

TABLE 11

PEPTIDE SYNTHESIS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024

TABLE 12

IMPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD)

TABLE 13

EXPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD)

TABLE 14

IMPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD)

TABLE 15

EXPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD)

TABLE 16

PEPTIDE SYNTHESIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026

TABLE 17

NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 18

EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 19

ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 20

LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 21

MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 22

PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS

TABLE 23

INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS

TABLE 24

KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER

TABLE 25

PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 26

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 27

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 28

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 29

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 30

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 31

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 32

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 33

PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 34

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 35

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 36

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 37

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 38

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 39

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 40

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 41

PEPTIDE CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 42

PEPTIDE CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 43

NORTH AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 44

EUROPE: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 45

ASIA PACIFIC: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 46

LATIN AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 47

MIDDLE EAST: PEPTIDE CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 48

GCC COUNTRIES: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 49

REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 50

REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 51

NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 52

EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 53

ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 54

LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 55

MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 56

GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 57

RESINS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 58

NORTH AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 59

EUROPE: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 60

ASIA PACIFIC: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 61

LATIN AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 62

MIDDLE EAST: RESINS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 63

GCC COUNTRIES: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 64

AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 65

NORTH AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 66

EUROPE: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 67

ASIA PACIFIC: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 68

LATIN AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 69

MIDDLE EAST: AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 70

GCC COUNTRIES: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 71

COUPLING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 72

NORTH AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 73

EUROPE: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 74

ASIA PACIFIC: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 75

LATIN AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 76

MIDDLE EAST: COUPLING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 77

GCC COUNTRIES: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 78

DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 79

NORTH AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 80

EUROPE: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 81

ASIA PACIFIC: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 82

LATIN AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 83

MIDDLE EAST: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 84

GCC COUNTRIES: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 85

DEPROTECTION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 86

NORTH AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 87

EUROPE: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 88

ASIA PACIFIC: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 89

LATIN AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 90

MIDDLE EAST: DEPROTECTION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 91

GCC COUNTRIES: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 92

CLEAVAGE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 93

NORTH AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 94

EUROPE: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 95

ASIA PACIFIC: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 96

LATIN AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 97

MIDDLE EAST: CLEAVAGE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 98

GCC COUNTRIES: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 99

OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 100

NORTH AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 101

EUROPE: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 102

ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 103

LATIN AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 104

MIDDLE EAST: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 105

GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 106

OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 107

NORTH AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, 2022–2029 (USD MILLION)

TABLE 108

EUROPE: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 109

ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 110

LATIN AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 111

MIDDLE EAST: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 112

GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 113

PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 114

PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 115

NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 116

EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 117

ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 118

LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 119

MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 120

GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 121

PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 122

PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 123

NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 124

EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 125

ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 126

LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 127

MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 128

GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 129

AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 130

NORTH AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 131

EUROPE: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 132

ASIA PACIFIC: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 133

LATIN AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 134

MIDDLE EAST: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 135

GCC COUNTRIES: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 136

MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 137

NORTH AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 138

EUROPE: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 139

ASIA PACIFIC: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 140

LATIN AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 141

MIDDLE EAST: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 142

GCC COUNTRIES: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 143

CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 144

NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 145

EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 146

ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 147

LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 148

MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 149

GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 150

LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 151

NORTH AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 152

EUROPE: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 153

ASIA PACIFIC: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 154

LATIN AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 155

MIDDLE EAST: LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 156

GCC COUNTRIES: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 157

OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 158

NORTH AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 159

EUROPE: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 160

ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 161

LATIN AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 162

MIDDLE EAST: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 163

GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 164

PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 165

PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 166

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 167

EUROPE: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 168

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 169

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 170

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 171

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 172

PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 173

NORTH AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 174

EUROPE: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 175

ASIA PACIFIC: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 176

LATIN AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 177

MIDDLE EAST: PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 178

GCC COUNTRIES: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 179

PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 180

NORTH AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 181

EUROPE: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 182

ASIA PACIFIC: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 183

LATIN AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 184

MIDDLE EAST: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 185

GCC COUNTRIES: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 186

PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 187

NORTH AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 188

EUROPE: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 189

ASIA PACIFIC: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 190

LATIN AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 191

MIDDLE EAST: PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 192

GCC COUNTRIES: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 193

PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 194

PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 195

PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 196

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 197

EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 198

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 199

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 200

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 201

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 202

SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 203

NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 204

EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 205

ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 206

LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 207

MIDDLE EAST: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 208

GCC COUNTRIES: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 209

LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 210

NORTH AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 211

EUROPE: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 212

ASIA PACIFIC: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 213

LATIN AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 214

MIDDLE EAST: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 215

GCC COUNTRIES: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 216

PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 217

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 218

EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 219

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 220

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 221

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 222

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 223

PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 224

PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 225

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 226

EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 227

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 228

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 229

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022–2029 (USD MILLION)

TABLE 230

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 231

PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 232

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 233

EUROPE: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 234

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 235

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 236

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)

TABLE 237

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 238

PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)

TABLE 239

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 240

EUROPE: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 241

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 242

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 243

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022–2029 (USD MILLION)

TABLE 244

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 245

PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 246

PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 247

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 248

EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 249

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 250

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 251

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 252

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 253

PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 254

PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION)

TABLE 255

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 256

EUROPE: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 257

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 258

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 259

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION)

TABLE 260

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 261

PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)

TABLE 262

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 263

EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 264

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 265

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 266

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION)

TABLE 267

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 268

PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022–2029 (USD MILLION)

TABLE 269

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 270

EUROPE: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 271

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 272

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 273

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022–2029 (USD MILLION)

TABLE 274

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 275

PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 276

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 277

EUROPE: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 278

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 279

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 280

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 281

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 282

PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 283

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 284

EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 285

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 286

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 287

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION)

TABLE 288

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 289

PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 290

PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022–2029 (USD MILLION)

TABLE 291

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 292

EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 293

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 294

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 295

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022–2029 (USD MILLION)

TABLE 296

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 297

PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION)

TABLE 298

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 299

EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 300

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 301

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 302

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION)

TABLE 303

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 304

PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022–2029 (USD MILLION)

TABLE 305

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 306

EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 307

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 308

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 309

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022–2029 (USD MILLION)

TABLE 310

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 311

PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022–2029 (USD MILLION)

TABLE 312

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 313

EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 314

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 315

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 316

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022–2029 (USD MILLION)

TABLE 317

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 318

PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 319

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 320

EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 321

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 322

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 323

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 324

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 325

PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 326

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 327

EUROPE: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 328

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 329

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 330

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 331

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 332

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 333

PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 334

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 335

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 336

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 337

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 338

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 339

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 340

PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 341

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 342

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 343

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 344

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 345

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 346

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 347

PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 348

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 349

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 350

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 351

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 352

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 353

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 354

PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 355

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 356

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 357

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 358

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 359

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 360

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 361

PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)

TABLE 362

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 363

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 364

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 365

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 366

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)

TABLE 367

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 368

PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 369

PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 370

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 371

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 372

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 373

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 374

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 375

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 376

PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 377

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 378

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 379

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 380

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 381

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)

TABLE 382

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 383

PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)

TABLE 384

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 385

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 386

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 387

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 388

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)

TABLE 389

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 390

PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 391

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 392

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 393

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 394

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 395

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)

TABLE 396

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 397

PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 398

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 399

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 400

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 401

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 402

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION)

TABLE 403

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 404

PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 405

KEY MACROECONOMIC INDICATORS FOR NORTH AMERICA

TABLE 406

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 407

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 408

NORTH AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 409

NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 410

NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 411

NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 412

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 413

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 414

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 415

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 416

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 417

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 418

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 419

NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 420

NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 421

US: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 422

US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 423

US: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 424

US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 425

US: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 426

US: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 427

US: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 428

US: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 429

US: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 430

US: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 431

US: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 432

US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 433

US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 434

US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 435

US: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 436

CANADA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 437

CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 438

CANADA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 439

CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 440

CANADA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 441

CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 442

CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 443

CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 444

CANADA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 445

CANADA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 446

CANADA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 447

CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 448

CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 449

CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 450

CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 451

KEY MACROECONOMIC INDICATORS FOR EUROPE

TABLE 452

EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 453

EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 454

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 455

EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 456

EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 457

EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 458

EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 459

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 460

EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 461

EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 462

EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 463

EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 464

EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 465

EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 466

EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 467

EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 468

GERMANY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 469

GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 470

GERMANY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 471

GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 472

GERMANY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 473

GERMANY: PEPTIDE SYNTHESIS SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 474

GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 475

GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 476

GERMANY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 477

GERMANY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 478

GERMANY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 479

GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 480

GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 481

GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 482

GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 483

UK: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 484

UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 485

UK: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 486

UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 487

UK: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 488

UK: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 489

UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 490

UK: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 491

UK: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 492

UK: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 493

UK: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 494

UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 495

UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 496

UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 497

UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 498

FRANCE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 499

FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 500

FRANCE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 501

FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 502

FRANCE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 503

FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 504

FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 505

FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 506

FRANCE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 507

FRANCE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 508

FRANCE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 509

FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 510

FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 511

FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 512

FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 513

ITALY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 514

ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 515

ITALY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 516

ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 517

ITALY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 518

ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 519

ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 520

ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 521

ITALY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 522

ITALY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 523

ITALY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 524

ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 525

ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 526

ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 527

ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 528

SPAIN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 529

SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 530

SPAIN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 531

SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 532

SPAIN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 533

SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 534

SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 535

SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 536

SPAIN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 537

SPAIN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 538

SPAIN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 539

SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 540

SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 541

SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 542

SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 543

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 544

REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 545

REST OF EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 546

REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 547

REST OF EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 548

REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 549

REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 550

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 551

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 552

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 553

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 554

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 555

REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 556

REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 557

REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 558

KEY MACROECONOMIC INDICATORS FOR ASIA PACIFIC

TABLE 559

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 560

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 561

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 562

ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 563

ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 564

ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 565

ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 566

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 567

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 568

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 569

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 570

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 571

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 572

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 573

ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 574

ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 575

CHINA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 576

CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 577

CHINA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 578

CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 579

CHINA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 580

CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 581

CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 582

CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 583

CHINA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 584

CHINA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 585

CHINA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 586

CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 587

CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 588

CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 589

CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 590

JAPAN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 591

JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 592

JAPAN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 593

JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 594

JAPAN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 595

JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 596

JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 597

JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 598

JAPAN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 599

JAPAN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 600

JAPAN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 601

JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 602

JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 603

JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 604

JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 605

INDIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 606

INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 607

INDIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 608

INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 609

INDIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 610

INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 611

INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 612

INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 613

INDIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 614

INDIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 615

INDIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 616

INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 617

INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 618

INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 619

INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 620

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 621

SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 622

SOUTH KOREA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 623

SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 624

SOUTH KOREA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 625

SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 626

SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 627

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 628

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 629

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 630

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 631

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 632

SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 633

SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 634

SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 635

AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 636

AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 637

AUSTRALIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 638

AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 639

AUSTRALIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 640

AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 641

AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 642

AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 643

AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 644

AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 645

AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 646

AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 647

AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 648

AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 649

AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 650

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 651

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 652

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 653

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 654

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 655

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 656

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 657

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 658

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 659

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 660

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 661

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 662

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 663

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 664

REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 665

KEY MACROECONOMIC INDICATORS FOR LATIN AMERICA

TABLE 666

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 667

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 668

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 669

LATIN AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 670

LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 671

LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 672

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 673

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 674

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 675

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 676

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 677

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 678

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 679

LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 680

LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 681

LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 682

BRAZIL: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 683

BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 684

BRAZIL: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 685

BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 686

BRAZIL: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 687

BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 688

BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 689

BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 690

BRAZIL: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 691

BRAZIL: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 692

BRAZIL: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 693

BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 694

BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 695

BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 696

BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 697

MEXICO: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 698

MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 699

MEXICO: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 700

MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 701

MEXICO: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 702

MEXICO: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 703

MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 704

MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 705

MEXICO: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 706

MEXICO: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 707

MEXICO: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 708

MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 709

MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 710

MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 711

MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 712

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 713

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 714

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)

TABLE 715

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 716

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 717

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 718

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 719

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 720

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 721

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 722

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 723

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 724

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 725

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 726

REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 727

KEY MACROECONOMIC INDICATORS FOR MIDDLE EAST

TABLE 728

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 729

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 730

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 731

MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 732

MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 733

MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 734

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 735

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 736

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 737

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 738

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 739

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 740

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 741

MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 742

MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 743

MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 744

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 745

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 746

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PRODUCTS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 747

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)

TABLE 748

GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 749

GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 750

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 751

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 752

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 753

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 754

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 755

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 756

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 757

GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 758

GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 759

GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 760

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 761

SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 762

SAUDI ARABIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 763

SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 764

SAUDI ARABIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 765

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 766

SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 767

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 768

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHOD, BY TYPE, 2022–2029 (USD MILLION)

TABLE 769

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 770

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 771

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 772

SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 773

SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 774

SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 775

UAE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 776

UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 777

UAE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 778

UAE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 779

UAE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 780

UAE: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 781

UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 782

UAE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 783

UAE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 784

UAE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 785

UAE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 786

UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 787

UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 788

UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 789

UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 790

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 791

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 792

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 793

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 794

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 795

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 796

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 797

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 798

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 799

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 800

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 801

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 802

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 803

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 804

REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 805

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 806

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 807

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 808

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 809

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 810

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 811

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 812

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 813

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 814

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 815

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 816

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 817

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 818

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 819

REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 820

KEY MACROECONOMIC INDICATORS FOR AFRICA

TABLE 821

AFRICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)

TABLE 822

AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 823

AFRICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 824

AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 825

AFRICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 826

AFRICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 827

AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 828

AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)

TABLE 829

AFRICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 830

AFRICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)

TABLE 831

AFRICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 832

AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)

TABLE 833

AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)

TABLE 834

AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 835

AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 836

OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025

TABLE 837

PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION

TABLE 838

PEPTIDE SYNTHESIS MARKET: REGION FOOTPRINT

TABLE 839

PEPTIDE SYNTHESIS MARKET: OFFERING FOOTPRINT

TABLE 840

PEPTIDE SYNTHESIS MARKET: TECHNIQUE FOOTPRINT

TABLE 841

PEPTIDE SYNTHESIS MARKET: APPLICATION FOOTPRINT

TABLE 842

PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES

TABLE 843

PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES

TABLE 844

PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024

TABLE 845

PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2021–DECEMBER 2024

TABLE 846

PEPTIDE SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024

TABLE 847

THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW

TABLE 848

THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED

TABLE 849

THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024

TABLE 850

MERCK KGAA: COMPANY OVERVIEW

TABLE 851

MERCK KGAA: PRODUCTS/SERVICES OFFERED

TABLE 852

AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW

TABLE 853

AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED

TABLE 854

GENSCRIPT: COMPANY OVERVIEW

TABLE 855

GENSCRIPT: PRODUCTS/SERVICES OFFERED

TABLE 856

GENSCRIPT: EXPANSIONS, JANUARY 2021−DECEMBER 2024

TABLE 857

KANEKA CORPORATION: COMPANY OVERVIEW

TABLE 858

KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 859

KANEKA CORPORATION: EXPANSIONS, JANUARY 2021−DECEMBER 2024

TABLE 860

BACHEM: COMPANY OVERVIEW

TABLE 861

BACHEM: PRODUCTS/SERVICES OFFERED

TABLE 862

BACHEM: DEALS, JANUARY 2021−DECEMBER 2024

TABLE 863

SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW

TABLE 864

SYNGENE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED

TABLE 865

MESA LABS, INC.: COMPANY OVERVIEW

TABLE 866

MESA LABS, INC.: PRODUCTS/SERVICES OFFERED

TABLE 867

MESA LABS, INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024

TABLE 868

MESA LABS, INC.: DEALS, JANUARY 2021−DECEMBER 2024

TABLE 869

BIOTAGE: COMPANY OVERVIEW

TABLE 870

BIOTAGE: PRODUCTS/SERVICES OFFERED

TABLE 871

CEM CORPORATION: COMPANY OVERVIEW

TABLE 872

CEM CORPORATION: PRODUCTS/SERVICES OFFERED

TABLE 873

CEM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024

TABLE 874

CEM CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024

TABLE 875

DALTON PHARMA SERVICES: COMPANY OVERVIEW

TABLE 876

DALTON PHARMA SERVICES: PRODUCTS/SERVICES OFFERED

TABLE 877

BIO-SYNTHESIS INC.: COMPANY OVERVIEW

TABLE 878

BIO-SYNTHESIS INC.: PRODUCTS/SERVICES OFFERED

TABLE 879

CSBIO: COMPANY OVERVIEW

TABLE 880

CSBIO: PRODUCTS/SERVICES OFFERED

TABLE 881

PROTEOGENIX: COMPANY OVERVIEW

TABLE 882

PROTEOGENIX: PRODUCTS/SERVICES OFFERED

TABLE 883

INNOVAGEN AB: COMPANY OVERVIEW

TABLE 884

INNOVAGEN AB: PRODUCTS/SERVICES OFFERED

TABLE 885

BIOSYNTH: COMPANY OVERVIEW

TABLE 886

BIOSYNTH: PRODUCTS/SERVICES OFFERED

TABLE 887

BIOSYNTH: DEALS, JANUARY 2021−DECEMBER 2024

TABLE 888

AURIGENE PHARMACEUTICAL SERVICES LTD.: COMPANY OVERVIEW

TABLE 889

CORDENPHARMA: COMPANY OVERVIEW

TABLE 890

JPT PEPTIDE TECHNOLOGIES: COMPANY OVERVIEW

TABLE 891

PUROLITE: COMPANY OVERVIEW

TABLE 892

BIOMATIK: COMPANY OVERVIEW

TABLE 893

CPC SCIENTIFIC INC.: COMPANY OVERVIEW

TABLE 894

ADVANCED CHEMTECH, INC.: COMPANY OVERVIEW

TABLE 895

AMBIOPHARM INC.: COMPANY OVERVIEW

TABLE 896

LUXEMBOURG BIO TECHNOLOGIES: COMPANY OVERVIEW

TABLE 897

AAPPTEC: COMPANY OVERVIEW

TABLE 898

ANYGEN: COMPANY OVERVIEW

TABLE 899

CHEMPEP: COMPANY OVERVIEW

TABLE 900

PROTEOGENIX: COMPANY OVERVIEW

LIST OF FIGURES

FIGURE 1

PEPTIDE SYNTHESIS MARKET SEGMENTATION

FIGURE 2

PEPTIDE SYNTHESIS MARKET: RESEARCH DESIGN

FIGURE 3

PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS

FIGURE 4

PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023

FIGURE 5

GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023

FIGURE 6

ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023

FIGURE 7

MARKET SIZE VALIDATION FROM PRIMARY SOURCES

FIGURE 8

MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH

FIGURE 9

PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS

FIGURE 10

DATA TRIANGULATION METHODOLOGY

FIGURE 11

PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)

FIGURE 12

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)

FIGURE 13

PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)

FIGURE 14

PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)

FIGURE 15

PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)

FIGURE 16

PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)

FIGURE 17

PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)

FIGURE 18

GEOGRAPHICAL SNAPSHOT OF PEPTIDE SYNTHESIS MARKET, 2024–2029

FIGURE 19

EXPANDING APPLICATIONS OF PEPTIDES IN DIAGNOSTICS, THERAPEUTICS, AND VACCINES TO DRIVE MARKET

FIGURE 20

CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2023

FIGURE 21

PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD

FIGURE 22

CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

FIGURE 23

PEPTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

FIGURE 24

TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

FIGURE 25

AVERAGE SELLING PRICE OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2024

FIGURE 26

AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY TYPE, 2022–2024

FIGURE 27

AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2024

FIGURE 28

PEPTIDE SYNTHESIS MARKET: SUPPLY CHAIN ANALYSIS

FIGURE 29

PEPTIDE SYNTHESIS MARKET: VALUE CHAIN ANALYSIS

FIGURE 30

PEPTIDE SYNTHESIS MARKET: ECOSYSTEM ANALYSIS

FIGURE 31

PEPTIDE SYNTHESIS MARKET: PATENT ANALYSIS, 2014−2024

FIGURE 32

PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 33

INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS

FIGURE 34

KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER

FIGURE 35

NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT

FIGURE 36

ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT

FIGURE 37

REVENUE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2019–2023

FIGURE 38

MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2023

FIGURE 39

YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025

FIGURE 40

EV/EBITDA OF KEY VENDORS, 2025

FIGURE 41

PEPTIDE SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS

FIGURE 42

PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023

FIGURE 43

PEPTIDE SYNTHESIS MARKET: COMPANY FOOTPRINT

FIGURE 44

PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023

FIGURE 45

THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)

FIGURE 46

MERCK KGAA: COMPANY SNAPSHOT (2023)

FIGURE 47

AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)

FIGURE 48

GENSCRIPT: COMPANY SNAPSHOT (2023)

FIGURE 49

KANEKA CORPORATION: COMPANY SNAPSHOT (2023)

FIGURE 50

BACHEM: COMPANY SNAPSHOT (2023)

FIGURE 51

SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)

FIGURE 52

MESA LABS, INC.: COMPANY SNAPSHOT (2023)

FIGURE 53

BIOTAGE: COMPANY SNAPSHOT (2023)

Methodology

The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size is estimated through secondary research (top-down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the peptide synthesis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), National Institutes of Health (NIH), Health Canada, Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the Association of Biomolecular Resource Facilities, Journal of the American Chemical Society, American Peptide Society, Australian Peptide Association, European Peptide Society, Indian Peptide Society, Protein Science Society of Japan (PSSJ), American Peptide Society (APS), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global peptide synthesis market, which was further validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global peptide synthesis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biopharmaceutical industries, CROS & CDMOs and among others from the supply side, such as C-level and D-level executives, product/service managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 65% and 35% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the peptide synthesis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Peptide synthesis is the process of creating peptides, which are short chains of amino acids linked by peptide bonds. These molecules are essential in biological systems and are widely used in research, diagnostics, and therapeutics. Peptide synthesis typically occurs through solid-phase synthesis (SPPS), liquid-phase synthesis, or hybrid approaches, enabling precise control over sequence and structure. SPPS, the most common method, involves anchoring the peptide to a solid resin, allowing stepwise addition of amino acids.

Stakeholders

Companies Providing Peptide Synthesis Services
Research Institutes and Academic Centers
Suppliers and Distributors of Peptide synthesis
Pharmaceutical and Biotechnology Companies
Business Research and Consulting Service Providers
Venture Capitalists
Contract Research Organizations and Contract Development Manufacturing Organizations
Market research and consulting firms

Report Objectives

To define, describe, and forecast the peptide synthesis market by value by offerings, products, consumables, services, application, technique, end user and region
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall peptide synthesis market
To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
To profile the key players and analyze their market shares and core competencies2
To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

OVERVIEW

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Advancements in peptide therapeutics

Restraint: Regulatory hurdles

Opportunity: Adoption of personalized medicine

Challenge: Immunogenicity issues

peptide-synthesis-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Peptide Synthesis Market, By Offerings

By Product Type

By Service Type

By Technique

By Application

By Product End user

By Service End user

REGION

Asia Pacific to be fastest-growing region in global pepdite synthesis market during forecast period

peptide-synthesis-market: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: peptide-synthesis-market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Stakeholders

Report Objectives

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

Growth opportunities and latent adjacency in Peptide Synthesis Market